New drugs and targeted treatments in Hodgkin’s lymphoma
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference75 articles.
1. Brentuximab vedotin and panobinostat: new drugs for Hodgkin’s lymphoma – can they make one of medical oncology’s chemotherapy success stories more successful?;Canellos;J Clin Oncol,2012
2. Curability of advanced Hodgkin’s disease with chemotherapy: long-term follow-up of MOPP-treated patients at the National Cancer Institute;De Vita;Ann Intern Med,1980
3. ABVD chemotherapy in the treatment of Hodgkin’s disease;Bonadonna;Cancer Treat Rev,1982
4. Pathobiology of Hodgkin lymphoma;Piccaluga;Adv Hematol,2011
5. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin’s lymphoma;Majhail;Biol Blood Marrow Transplant,2006
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Hodgkin’s lymphoma pharmacotherapy: a focus on histone deacetylase inhibitors;Expert Opinion on Pharmacotherapy;2023-06-02
2. Outcome of Classical Hodgkin’s Lymphoma Treatment Based on HighDose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery;Clinical oncohematology;2018
3. Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma;Hematology;2016-03
4. Checkpoint inhibitors in Hodgkin's lymphoma;European Journal of Haematology;2015-12-11
5. Immunotoxin – a new treatment option in patients with relapsed and refractory Hodgkin lymphoma;Radiology and Oncology;2015-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3